Apath, LLC is a leading biotechnology company based in New York, specializing in the development and licensing of innovative technologies for the screening and research of Hepatitis C Virus (HCV). With a strong focus on HCV-related intellectual property, Apath offers a comprehensive range of development platforms, research tools, and sublicensing opportunities to clients worldwide.
Through strategic partnerships with renowned institutions such as The Rockefeller University and Washington University, Apath has expanded its HCV technology portfolio, providing clients with access to cutting-edge anti-HCV development platforms and exceptional research and development tools. With a team of experienced virologists, Apath offers harmonized development solutions to meet the diverse needs of its global licensees.
Generated from the website